The Valley Desk

NCT04638647 · Interventional trial

Secukinumab Open Label Roll-over Extension Protocol

Overall registry status Recruiting

Phase 4

Conditions Autoimmunity, Inflammation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov